NO20032830L - Tetrahydropyridinderivater, fremstilling derav og anvendelse som celleproliferasjonsinhibitorer - Google Patents
Tetrahydropyridinderivater, fremstilling derav og anvendelse som celleproliferasjonsinhibitorerInfo
- Publication number
- NO20032830L NO20032830L NO20032830A NO20032830A NO20032830L NO 20032830 L NO20032830 L NO 20032830L NO 20032830 A NO20032830 A NO 20032830A NO 20032830 A NO20032830 A NO 20032830A NO 20032830 L NO20032830 L NO 20032830L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- cell proliferation
- proliferation inhibitors
- tetrahydropyridine derivatives
- tetrahydropyridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00128487 | 2000-12-23 | ||
PCT/EP2001/015390 WO2002051842A1 (en) | 2000-12-23 | 2001-12-21 | Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20032830D0 NO20032830D0 (no) | 2003-06-20 |
NO20032830L true NO20032830L (no) | 2003-08-04 |
Family
ID=8170814
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20032830A NO20032830L (no) | 2000-12-23 | 2003-06-20 | Tetrahydropyridinderivater, fremstilling derav og anvendelse som celleproliferasjonsinhibitorer |
Country Status (27)
Country | Link |
---|---|
US (1) | US6800638B2 (zh) |
EP (1) | EP1353921B1 (zh) |
JP (1) | JP2004516325A (zh) |
KR (1) | KR100836545B1 (zh) |
CN (1) | CN1213046C (zh) |
AR (1) | AR035513A1 (zh) |
AT (1) | ATE323700T1 (zh) |
AU (1) | AU2002226397B2 (zh) |
BG (1) | BG107935A (zh) |
BR (1) | BR0116402A (zh) |
CA (1) | CA2431471A1 (zh) |
CZ (1) | CZ20031940A3 (zh) |
DE (1) | DE60118975T2 (zh) |
EC (1) | ECSP034664A (zh) |
ES (1) | ES2261519T3 (zh) |
HU (1) | HUP0400554A2 (zh) |
IL (1) | IL156131A0 (zh) |
MA (1) | MA26976A1 (zh) |
MX (1) | MXPA03005713A (zh) |
NO (1) | NO20032830L (zh) |
NZ (1) | NZ526189A (zh) |
PL (1) | PL365531A1 (zh) |
RU (1) | RU2276140C2 (zh) |
SK (1) | SK9122003A3 (zh) |
WO (1) | WO2002051842A1 (zh) |
YU (1) | YU48803A (zh) |
ZA (1) | ZA200304264B (zh) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6706686B2 (en) | 2001-09-27 | 2004-03-16 | The Regents Of The University Of Colorado | Inhibition of histone deacetylase as a treatment for cardiac hypertrophy |
EP2269609A3 (en) | 2001-10-16 | 2012-07-11 | Sloan-Kettering Institute for Cancer Research | Treatment of neurodegenerative diseases and cancer of the brain with SAHA |
AU2003218508A1 (en) | 2002-04-01 | 2003-10-13 | Ranko Rakanovic | Rubber elastic element |
US7154002B1 (en) | 2002-10-08 | 2006-12-26 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
US7250514B1 (en) | 2002-10-21 | 2007-07-31 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
AU2003900608A0 (en) * | 2003-02-11 | 2003-02-27 | Fujisawa Pharmaceutical Co., Ltd. | Hdac inhibitor |
JP2006520796A (ja) | 2003-03-17 | 2006-09-14 | タケダ サン ディエゴ インコーポレイテッド | ヒストンデアセチラーゼインヒビター |
US20060235012A1 (en) * | 2003-06-16 | 2006-10-19 | Chroma Therapeutics Limited | Carboline and betacarboline derivatives for use as hdac enzyme inhibitors |
EP1694329A4 (en) * | 2003-11-26 | 2009-06-03 | Aton Pharma Inc | DIAMOND AND IMINODIACETIC ACID HYDROXAMINIC DERIVATIVES |
US20050137234A1 (en) * | 2003-12-19 | 2005-06-23 | Syrrx, Inc. | Histone deacetylase inhibitors |
WO2005065681A1 (en) * | 2003-12-19 | 2005-07-21 | Takeda San Diego, Inc. | N- hydroxy-3-(3-(1h-imidazol-2-yl)-phenyl)-acrylamide derivatives and related compounds as histone deacetylase (hdac) inhibitors for the treatment of cancer |
EP1824831A2 (en) | 2004-12-16 | 2007-08-29 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
WO2006088949A1 (en) | 2005-02-14 | 2006-08-24 | Miikana Therapeutics, Inc. | Fused heterocyclic compounds useful as inhibitors of histone deacetylase |
GB0509223D0 (en) | 2005-05-05 | 2005-06-15 | Chroma Therapeutics Ltd | Enzyme inhibitors |
JP2008540574A (ja) | 2005-05-11 | 2008-11-20 | タケダ サン ディエゴ インコーポレイテッド | ヒストンデアセチラーゼ阻害剤 |
BRPI0613429A2 (pt) | 2005-07-14 | 2009-02-10 | Takeda San Diego Inc | inibidores de histona desacetilase |
EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
EP2275095A3 (en) | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
EP2377530A3 (en) | 2005-10-21 | 2012-06-20 | Braincells, Inc. | Modulation of neurogenesis by PDE inhibition |
EP2314289A1 (en) | 2005-10-31 | 2011-04-27 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
WO2007084390A2 (en) * | 2006-01-13 | 2007-07-26 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
CA2651813A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
WO2007134077A2 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
AU2007292848A1 (en) | 2006-09-08 | 2008-03-13 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
TWI425945B (zh) * | 2007-05-28 | 2014-02-11 | Seldar Pharma Inc | 四氫異喹啉-1-酮衍生物或其鹽 |
US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
ES2736200T3 (es) * | 2009-07-22 | 2019-12-26 | Univ Illinois | Inhibidores de HDAC y métodos terapéuticos que utilizan los mismos |
CN102153549B (zh) * | 2010-12-14 | 2012-11-14 | 华东理工大学 | γ咔啉化合物、制备方法和用途 |
KR101645379B1 (ko) | 2013-04-29 | 2016-08-03 | 주식회사 종근당 | 선택적 히스톤 탈아세틸화 효소 억제제로서의 신규 화합물 및 이를 포함하는 약제학적 조성물 |
US10184933B2 (en) | 2013-10-01 | 2019-01-22 | The J. David Gladstone Industries | Compositions, systems and methods for gene expression noise drug screening and uses thereof |
CN108084178B (zh) * | 2018-01-04 | 2020-09-01 | 济南大学 | 一类含有四氢-β-咔碄结构的异羟肟酸类化合物的用途 |
CN108558653A (zh) * | 2018-05-14 | 2018-09-21 | 湖南华腾制药有限公司 | 赛乐西帕中间体及赛乐西帕的制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990002119A1 (en) | 1988-08-18 | 1990-03-08 | Banyu Pharmaceutical Co., Ltd. | 1,2,3,4-tetrahydroisoquinoline derivatives |
US5369108A (en) | 1991-10-04 | 1994-11-29 | Sloan-Kettering Institute For Cancer Research | Potent inducers of terminal differentiation and methods of use thereof |
WO1998007421A1 (fr) | 1996-08-16 | 1998-02-26 | Ishihara Sangyo Kaisha, Ltd. | Composition medicinale |
WO1998015525A1 (fr) * | 1996-10-07 | 1998-04-16 | Sumitomo Pharmaceuticals Co., Ltd. | Acides hydroxamiques |
AUPO721997A0 (en) | 1997-06-06 | 1997-07-03 | Queensland Institute Of Medical Research, The | Anticancer compounds |
JP2003525203A (ja) * | 1999-03-22 | 2003-08-26 | ダーウィン・ディスカバリー・リミテッド | ヒドロキサムおよびカルボン酸誘導体 |
-
2001
- 2001-12-06 AR ARP010105675A patent/AR035513A1/es not_active Application Discontinuation
- 2001-12-21 CA CA002431471A patent/CA2431471A1/en not_active Abandoned
- 2001-12-21 SK SK912-2003A patent/SK9122003A3/sk unknown
- 2001-12-21 CZ CZ20031940A patent/CZ20031940A3/cs unknown
- 2001-12-21 IL IL15613101A patent/IL156131A0/xx unknown
- 2001-12-21 AU AU2002226397A patent/AU2002226397B2/en not_active Ceased
- 2001-12-21 AT AT01995721T patent/ATE323700T1/de not_active IP Right Cessation
- 2001-12-21 YU YU48803A patent/YU48803A/sh unknown
- 2001-12-21 WO PCT/EP2001/015390 patent/WO2002051842A1/en active IP Right Grant
- 2001-12-21 ES ES01995721T patent/ES2261519T3/es not_active Expired - Lifetime
- 2001-12-21 EP EP01995721A patent/EP1353921B1/en not_active Expired - Lifetime
- 2001-12-21 PL PL01365531A patent/PL365531A1/xx not_active Application Discontinuation
- 2001-12-21 BR BR0116402-3A patent/BR0116402A/pt not_active IP Right Cessation
- 2001-12-21 DE DE60118975T patent/DE60118975T2/de not_active Expired - Fee Related
- 2001-12-21 MX MXPA03005713A patent/MXPA03005713A/es active IP Right Grant
- 2001-12-21 HU HU0400554A patent/HUP0400554A2/hu unknown
- 2001-12-21 KR KR1020037008028A patent/KR100836545B1/ko not_active IP Right Cessation
- 2001-12-21 RU RU2003122190/04A patent/RU2276140C2/ru active
- 2001-12-21 JP JP2002552937A patent/JP2004516325A/ja not_active Ceased
- 2001-12-21 CN CNB018212050A patent/CN1213046C/zh not_active Expired - Fee Related
- 2001-12-21 NZ NZ526189A patent/NZ526189A/en unknown
- 2001-12-21 US US10/451,757 patent/US6800638B2/en not_active Expired - Fee Related
-
2003
- 2003-05-30 ZA ZA200304264A patent/ZA200304264B/en unknown
- 2003-06-20 NO NO20032830A patent/NO20032830L/no not_active Application Discontinuation
- 2003-06-20 MA MA27207A patent/MA26976A1/fr unknown
- 2003-06-22 EC EC2003004664A patent/ECSP034664A/es unknown
- 2003-06-23 BG BG107935A patent/BG107935A/bg unknown
Also Published As
Publication number | Publication date |
---|---|
ES2261519T3 (es) | 2006-11-16 |
NO20032830D0 (no) | 2003-06-20 |
AU2002226397B2 (en) | 2006-10-05 |
EP1353921B1 (en) | 2006-04-19 |
PL365531A1 (en) | 2005-01-10 |
WO2002051842A1 (en) | 2002-07-04 |
HUP0400554A2 (hu) | 2004-06-28 |
MXPA03005713A (es) | 2003-10-06 |
US20040053960A1 (en) | 2004-03-18 |
SK9122003A3 (en) | 2004-02-03 |
KR20030063424A (ko) | 2003-07-28 |
CN1213046C (zh) | 2005-08-03 |
DE60118975T2 (de) | 2006-12-21 |
ECSP034664A (es) | 2003-07-25 |
IL156131A0 (en) | 2003-12-23 |
ZA200304264B (en) | 2004-08-30 |
DE60118975D1 (de) | 2006-05-24 |
US6800638B2 (en) | 2004-10-05 |
RU2003122190A (ru) | 2005-02-27 |
AR035513A1 (es) | 2004-06-02 |
ATE323700T1 (de) | 2006-05-15 |
CA2431471A1 (en) | 2002-07-04 |
CZ20031940A3 (cs) | 2003-10-15 |
EP1353921A1 (en) | 2003-10-22 |
MA26976A1 (fr) | 2004-12-20 |
NZ526189A (en) | 2004-10-29 |
KR100836545B1 (ko) | 2008-06-10 |
BG107935A (bg) | 2004-08-31 |
BR0116402A (pt) | 2003-11-11 |
RU2276140C2 (ru) | 2006-05-10 |
YU48803A (sh) | 2006-05-25 |
CN1483033A (zh) | 2004-03-17 |
JP2004516325A (ja) | 2004-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20032830L (no) | Tetrahydropyridinderivater, fremstilling derav og anvendelse som celleproliferasjonsinhibitorer | |
NO20053356D0 (no) | Aminindazolderivater og anvendelse derav som kinaseinhibitorer. | |
DK1133477T3 (da) | Substituerede benzimidazoler og deres anvendelse som parpinhibitorer | |
DK1268431T3 (da) | 3-Cyanoquinoliner, 3-cyano-1,6-naphthyridiner og 3-cyano-1,7-naphthyridiner som proteinkinaseinhibitorer | |
NO20026010L (no) | Substituerte quinazolinderivater og deres anvendelse som inhibitorer | |
NO20006029D0 (no) | Pyrazolinderivater, deres fremstilling og anvendelse som legemidler | |
DK1095025T3 (da) | Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler | |
NO20025357D0 (no) | Antranylamider og deres anvendelse som legemidler | |
NO20005146D0 (no) | Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter | |
NO20031838D0 (no) | Benzokazinonderivater, deres fremstilling og anvendelse | |
NO20023146L (no) | Substituerte fenyl-piperazinderivater, deres fremstilling og anvendelse | |
DK1043307T3 (da) | 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse | |
DK1387838T3 (da) | Cyanoanthranylamid-derivater og deres anvendelse som lægemidler | |
DK1150996T3 (da) | Nye amidinobenzylaminderivater og deres anvendelse som thrombin-inhibitorer | |
NO20025504D0 (no) | Nye tiokromanderivater og anvendelse derav som trombininhibitorer | |
DK1214302T3 (da) | Substituerede 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-oner og deres anvendelse som lipasehæmmere | |
NO20016404L (no) | Naftyridinderivater, fremgangsmåter for deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse | |
IS7961A (is) | Díarýlmetýlídenpíperidínafleiður, lyfjablöndur þeirra og notkun þeirra | |
NO20030813L (no) | Bifenylderivater og deres anvendelse som integrininhibitorer | |
NO20025884L (no) | 2-aminotiazolinderivater og deres anvendelse som NO- syntaseinhibitorer | |
NO20024107L (no) | Tienopyridin derivater, deres fremstilling og anvendelse | |
DK1215213T3 (da) | Bicylliske aminopyrazinonderivater, fremstilling deraf og farmaceutiske sammensætninger, som indeholder disse | |
NO20001782L (no) | 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse | |
NO20025885D0 (no) | 4,5-dihydro-tiazol-2-ylaminderivater og deres anvendelse som NO-syntaseinhibitorer | |
DK1324980T3 (da) | Citrullimyciner, og fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |